STAAR Surgical Company (STAA)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, STAAR Surgical Company's Days of Sales Outstanding (DSO) figures are not available for the periods from March 31, 2020, to December 31, 2024. DSO is a metric used to measure the average number of days a company takes to collect revenue after a sale has been made.
Without specific DSO data, it is challenging to analyze the efficiency of STAAR Surgical Company's accounts receivable management and its ability to collect outstanding receivables in a timely manner. Monitoring DSO over time can provide insights into changes in the company's credit policies, customer payment behavior, and overall liquidity position.
Given the missing information, it is recommended for stakeholders and investors to request or refer to the company's financial reports or disclosures to obtain a clearer picture of STAAR Surgical Company's DSO performance and its implications for operational and financial health.
Peer comparison
Dec 31, 2024